IP Library Granted Patent US 12,377,262
Granted Patent B2
US 12,377,262 · App. 17/804,041 · Granted Aug 5, 2025

Method and implantable medical device for reducing defibrillation impedance

Inventors: Alexander R. Bornzin (Ventura, CA); Gene A. Bornzin (Los Angeles, CA); Zoltan Somogyi (Ventura, CA)
Assignee: Pacesetter, Inc.
A61N1/0563A61B17/3468A61N1/0504A61N1/0573A61N1/3752A61N1/3956
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,377,262
App. No.
17/804,041
Filed
May 25, 2022
Granted
Aug 5, 2025
Kind
B2
Art Unit
3792
USPC
607/5
Abstract

Methods and implantable medical devices are provided that include a lead configured to be operably coupled to a pulse generator and subcutaneously implanted within a patient. The lead includes an electrode configured to receive electrical power from the pulse generator and to deliver high-voltage shocks for defibrillation therapy. The electrode has an oblong cross-sectional shape with a major dimension that is at least 10 French (F).

Claims (23)

1. An implantable medical device (IMD) comprising:

a lead configured to be operably coupled to a pulse generator and subcutaneously implanted within a patient, the lead including first electrode and a second electrode configured to receive electrical power from the pulse generator and to deliver high-voltage shocks for defibrillation therapy, wherein the first electrode has a first oblong cross-sectional shape with a major dimension that is at least 10 French (F), the first oblong cross-sectional shape being a rectangle with rounded corners,

wherein the first electrode is configured to be located in a parasternal area of the patient, the second electrode is configured to provide the high-voltage shocks for the defibrillation therapy, the second electrode is disposed between the first electrode and the pulse generator along a length of the lead, the second electrode having a second oblong cross-sectional shape that is different from the first oblong cross-sectional shape of the first electrode.

2. The IMD of claim 1 , wherein the first oblong cross-sectional shape of the first electrode has a minor dimension that is less than the major dimension and oriented perpendicular to the major dimension.

3. The IMD of claim 2 , wherein an aspect ratio of the major dimension to the minor dimension is at least 2:1.

4. The IMD of claim 2 , wherein the minor dimension is at least 10 F and the major dimension is greater than 10 F.

5. The IMD of claim 1 , wherein the first oblong cross-sectional shape of the first electrode has first and second planar sides that are parallel to each other and third and fourth planar sides that are parallel to each other, each of the first and second planar sides connected with each of the third and fourth planar sides by the rounded corners.

6. The IMD of claim 1 , wherein the first electrode has a first orientation extending from a proximal end of the first electrode to a distal end of the first electrode, and the second electrode has a second orientation extending from a proximal end of the second electrode to a distal end of the second electrode, wherein the first orientation is transverse to the second orientation.

7. The IMD of claim 1 , wherein the first electrode comprises a plurality of electrically conductive brick segments that are coupled together in a line.

8. The IMD of claim 1 , further comprising the pulse generator, wherein the pulse generator is configured to supply the electrical power at less than 1000 V through the lead to the second electrode to provide the high-voltage shocks.

9. The IMD of claim 1 , further comprising the pulse generator, wherein the pulse generator has a volume less than 50 cm 3 .

10. The IMD of claim 1 , wherein the first electrode is longer than the second electrode.

11. The IMD of claim 1 , wherein the first electrode and the second electrode are spaced apart from each other along a length of the lead by a gap segment adapted to be positioned at a xiphoid process of the patient.

12. The IMD of claim 1 , wherein the first electrode is adapted to be positioned along an anterior region of a chest of the patient and the second electrode laterally extends between the primary electrode and the pulse generator.

13. The IMD of claim 1 , wherein the first electrode is adapted to be oriented parallel to a midsternal line of the patient while implanted in the patient, and the second electrode is oriented at an angle between sixty degrees and one hundred twenty degrees to the first electrode.

14. A method of producing an implantable medical device (IMD), the method comprising:

forming a lead that is configured to be operably coupled to a pulse generator and subcutaneously implanted within a patient; and

securing first and second electrodes on the lead, the first and second electrodes configured to receive electrical power from the pulse generator and to deliver high-voltage shocks for defibrillation therapy, wherein the first electrode has a first oblong cross-sectional shape with a major dimension that is at least 10 French (F), the first oblong cross-sectional shape being a rectangle with rounded corners, the first electrode secured on the lead to be located in a parasternal area of the patient, the second electrode secured on the lead to be located between the first electrode and the pulse generator along a length of the lead, the second electrode having a second oblong cross-sectional shape that is different from the first oblong cross-sectional shape of the first electrode.

15. The method of claim 14 , wherein the first oblong cross-sectional shape of the first electrode has a minor dimension that is less than the major dimension and is perpendicular to the major dimension, and an aspect ratio of the major dimension to the minor dimension is at least 2:1.

16. The method of claim 14 , further comprising implanting the lead such that the first electrode has a first orientation extending from a proximal end of the first electrode to a distal end of the first electrode, and the second electrode has a second orientation extending from a proximal end of the second electrode to a distal end of the second electrode, wherein the first orientation is transverse to the second orientation.

17. The method of claim 14 , wherein the first electrode and the second electrode are secured on the lead with the first electrode and the second electrode spaced apart from each other along a length of the lead by a gap segment positioned at a xiphoid process of the patient.

18. The method of claim 14 , wherein the first electrode and the second electrode are secured on the lead with the first electrode is positioned along an anterior region of a chest of the patient and the second electrode laterally extending between the primary electrode and the pulse generator.

19. The method of claim 14 , wherein the first electrode and the second electrode are secured on the lead with the first electrode oriented parallel to a midsternal line of the patient while implanted in the patient and the second electrode oriented at an angle between sixty degrees and one hundred twenty degrees to the first electrode.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2022
From: BORNZIN, ALEXANDER R.; BORNZIN, GENE A.; SOMOGYI, ZOLTAN
To: PACESETTER, INC.
Reel/Frame 060018/0273 →
Continuity (1)
Related Publication 20230381500A1 · Nov 30, 2023
References Cited (28)
US 5902236A · Iversen · 1999 [cited by examiner]
US 7363083B2 · Bardy et al. · 2008 [cited by applicant]
US 8483841B2 · Sanghera et al. · 2013 [cited by applicant]
US 9079035B2 · Sanghera et al. · 2015 [cited by applicant]
US 10137295B2 · Marshall et al. · 2018 [cited by applicant]
US 10391325B2 · De Kock et al. · 2019 [cited by applicant]
US 10661073B2 · Marshall et al. · 2020 [cited by applicant]
US 20070123940A1 · Dorr · 2007 [cited by examiner]
US 20160158567A1 · Marshall · 2016 [cited by examiner]
US 20160021392A1 · Rosenberg et al. · 2016 [cited by applicant]
US 20160213311A1 · Zhang · 2016 [cited by examiner]
US 20170319864A1 · De Kock · 2017 [cited by examiner]
US 20180272138A1 · Tahmasian · 2018 [cited by examiner]
US 20190336753A1 · Min · 2019 [cited by examiner]
US 20200376265A1 · Sanghera et al. · 2020 [cited by applicant]
US 20200398044A1 · Sanghera et al. · 2020 [cited by applicant]
US 20210370080A1 · Sanghera et al. · 2021 [cited by applicant]
US 20210370081A1 · Sanghera et al. · 2021 [cited by applicant]
EP 3976167A1 · 2022 [cited by applicant]
WO 2020243534A1 · 2020 [cited by applicant]
WO 2022009100A2 · 2022 [cited by applicant]
U.S. Appl. No. 63/049,561, filed Jul. 8, 2020 (18 pages). [cited by applicant]
U.S. Appl. No. 62/854,178, filed May 29, 2019 (91 pages). [cited by applicant]
User's manual, Emblemtm S-ICD, Electrode Delivery System, Model 4712. © 2017 Boston Scientific Corporation, <https://www.s-icd.es/content/dam/Manuals/us/current-rev-en/360244-001_EMBLEM_UM_en-USA_S.pdf>, (44 pages). [cited by applicant]
Frankel et al., “Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator”, ACC: Clinical Electrophysiology 2018, vol. 4, No. 5: 652-659, (8 pages). [cited by applicant]
Quast et al., “A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score”, Heart Rhythm 2019, 16: 403-410, (8 pages… [cited by applicant]
Amin et al, “Factors associated with high-voltage impedance and subcutaneous implantable defibrillator ventricular fibrillation conversion success”, Circ Arrhythm Electrophysiol 2019, (10 pages). [cited by applicant]
Heist et al, “Determinants of subcutaneous implantable cardioverter-defibrillator efficacy: a computer modeling study”, JACC Clin Electrophysiol 2017, 3:405-414, (10 pages). [cited by applicant]